EUROAPOTHECA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,919,000 | 6,459,000 | 4,947,000 | 5,948,000 | 6,021,000 | 8,961,000 | 8,325,000 | 10,620,000 |
| Profit before tax | 2,174,000 | 10,700,000 | 29,983,000 | 3,558,000 | 28,311,000 | 31,244,000 | -2,601,000 | 23,931,000 |
| Net profit | - | - | - | - | 28,319,000 | 31,164,000 | -2,648,000 | 25,401,000 |
| Equity | 365,196,000 | 375,404,000 | 383,453,000 | 375,732,000 | 405,406,000 | 390,611,000 | 377,963,000 | 373,363,000 |
| Liabilities | - | - | - | - | 55,718,000 | 70,139,000 | 58,597,000 | 53,257,000 |
| Non-current assets | 486,756,000 | 483,104,000 | 475,700,000 | 454,831,000 | 454,137,000 | 456,261,000 | 416,838,000 | 222,861,000 |
| Current assets | 15,169,000 | 13,663,000 | 14,777,000 | 2,974,000 | 6,987,000 | 4,489,000 | 19,722,000 | 34,412,000 |
| Total assets | 501,925,000 | 496,767,000 | 490,477,000 | 457,805,000 | 461,124,000 | 460,750,000 | 436,560,000 | 257,273,000 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,197,604 | 1,781,991 | 1,340,555 |
| Social insurance contributions | - | - | - | - | - | 819,474 | 1,029,779 | 1,040,754 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +43.6% | +31.3% | -23.4% | +20.2% | +1.2% | +48.8% | -7.1% | +27.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 6.1% | 6.8% | -0.6% | 9.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 7.0% | 8.0% | -0.7% | 6.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 470.3% | 347.8% | -31.8% | 239.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 44.2% | 165.7% | 606.1% | 59.8% | 470.2% | 348.7% | -31.2% | 225.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.1 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 78,390 | 87,778 | 92,611 | 108,309 | 103,661 | 139,110 | 110,387 | 132,474 |
Sales revenue
Consolidated EUROAPOTHECA finance
|
EUR
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 1,030,355,000 | 1,596,133,000 | 1,658,310,000 | 573,371,000 |
| Profit before tax | 35,468,000 | 30,344,000 | -16,933,000 | 22,346,000 |
| Net profit | 26,366,000 | 25,844,000 | -20,808,000 | -20,789,000 |
| Equity | 585,366,000 | 566,929,000 | 518,118,000 | 497,246,000 |
| Liabilities | 554,083,000 | 569,093,000 | 568,901,000 | 321,904,000 |
| Non-current assets | 799,197,000 | 820,075,000 | 750,441,000 | 271,638,000 |
| Current assets | 340,252,000 | 315,947,000 | 336,578,000 | 165,084,000 |
| Total assets | 1,139,449,000 | 1,136,022,000 | 1,087,019,000 | 436,722,000 |
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
EUROAPOTHECA - Social security debts
The company had no debts to Sodra
EUROAPOTHECA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
EUROAPOTHECA, UAB, a Private Limited Liability Company (code 300854822), operates in business and other management consultancy activities. In financial year 2025, revenue increased to €10.62M from €8.32M in 2024, after a 2023 level of €8.96M. Profitability also improved markedly: net profit reached €25.40M in 2025, following a loss of €2.65M in 2024 and a profit of €31.16M in 2023. The 2025 profit margin was exceptionally high at 239.2%, supported by strong earnings relative to turnover. The company’s balance sheet remained sizeable, although total assets decreased to €257.27M in 2025 from €436.56M in 2024 and €460.75M in 2023. Equity stood at €373.36M and liabilities at €53.26M, indicating a low-leverage position with a debt-to-equity ratio of 0.14. ROE was 6.8% and ROA 9.9% in 2025, while asset turnover remained low at 0.04x. Revenue per employee was €132.8K, with profit per employee of €317.5K.